Shirani A - Search Results

1

Interferon beta and long-term disability in multiple sclerosis.

Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Gustafson P, Petkau J, Tremlett H. Shirani A, et al. JAMA Neurol. 2013 May;70(5):651-2. doi: 10.1001/jamaneurol.2013.2197. JAMA Neurol. 2013. PMID: 23699948 No abstract available.

2

Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.

Shirani A, Cross AH, Stuve O. Shirani A, et al. Ther Adv Neurol Disord. 2024 Apr 1;17:17562864241241383. doi: 10.1177/17562864241241383. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 38566910 Free PMC article.

3

Disseminated Aspergillosis in a Patient With Neurosarcoidosis: Persistent Contrast Enhancement in CNS Despite Prolonged Antifungal Treatment: A Case Report.

Arcot Jayagopal L, Shirani A, Cawcutt K, Chen J, Yuil-Valdes A, Zabad R. Arcot Jayagopal L, et al. Among authors: shirani a. J Cent Nerv Syst Dis. 2023 Aug 12;15:11795735231195756. doi: 10.1177/11795735231195756. eCollection 2023. J Cent Nerv Syst Dis. 2023. PMID: 37581177 Free PMC article.

4

Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion.

Shirani A, Stuve O, Cross AH. Shirani A, et al. Neurol Clin. 2024 Feb;42(1):137-153. doi: 10.1016/j.ncl.2023.06.001. Epub 2023 Jul 23. Neurol Clin. 2024. PMID: 37980111 Review.

5

Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.

Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, Tremlett H. Kingwell E, et al. Among authors: shirani a. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):61-6. doi: 10.1136/jnnp-2011-300616. Epub 2011 Aug 23. J Neurol Neurosurg Psychiatry. 2012. PMID: 21865212

6

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).

Shirani A, Zhao Y, Kingwell E, Rieckmann P, Tremlett H. Shirani A, et al. Mult Scler. 2012 Apr;18(4):442-50. doi: 10.1177/1352458511422097. Epub 2011 Sep 27. Mult Scler. 2012. PMID: 21952097

7

The effect of smoking on the symptoms and progression of multiple sclerosis: a review.

Shirani A, Tremlett H. Shirani A, et al. J Inflamm Res. 2010;3:115-26. doi: 10.2147/JIR.S12059. Epub 2010 Sep 1. J Inflamm Res. 2010. PMID: 22096361 Free PMC article.

8

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.

Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Gustafson P, Petkau J, Tremlett H. Shirani A, et al. JAMA. 2012 Jul 18;308(3):247-56. doi: 10.1001/jama.2012.7625. JAMA. 2012. PMID: 22797642

9

Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.

Lourenco P, Shirani A, Saeedi J, Oger J, Schreiber WE, Tremlett H. Lourenco P, et al. Among authors: shirani a. Mult Scler. 2013 Apr;19(5):577-84. doi: 10.1177/1352458512459684. Epub 2012 Sep 7. Mult Scler. 2013. PMID: 22961214

10

Characterising aggressive multiple sclerosis.

Menon S, Shirani A, Zhao Y, Oger J, Traboulsee A, Freedman MS, Tremlett H. Menon S, et al. Among authors: shirani a. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1192-8. doi: 10.1136/jnnp-2013-304951. Epub 2013 Jun 6. J Neurol Neurosurg Psychiatry. 2013. PMID: 23744892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters